Explore

Trendline Trendline
ImmunityBio Faces Securities Fraud Class Action Over Misleading Claims on Cancer Drug

ImmunityBio Faces Securities Fraud Class Action Over Misleading Claims on Cancer Drug

ImmunityBio Faces Securities Fraud Class Action Over Misleading Claims on Cancer Drug
Trendline Trendline
Rosen Law Firm Investigates Disc Medicine, Inc. for Potential Securities Claims

Rosen Law Firm Investigates Disc Medicine, Inc. for Potential Securities Claims

Rosen Law Firm Investigates Disc Medicine, Inc. for Potential Securities Claims
Trendline Trendline
Hecla Mining Eliminates Long-Term Debt, Focuses on Silver Growth in Q1 2026

Hecla Mining Eliminates Long-Term Debt, Focuses on Silver Growth in Q1 2026

Hecla Mining Eliminates Long-Term Debt, Focuses on Silver Growth in Q1 2026
Trendline Trendline
Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaborations

Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaborations

Agenus Advances BOT+BAL Immunotherapy with Phase 3 Trial and Strategic Collaborations
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy with AI Enhancement
Trendline Trendline
Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement

Cellular Intelligence Acquires Novo Nordisk's Parkinson's Cell Therapy Program for Clinical Advancement
Trendline Trendline
Consolidated Water Reports 11% Revenue Decline in Q1 2026 Amid Manufacturing Challenges

Consolidated Water Reports 11% Revenue Decline in Q1 2026 Amid Manufacturing Challenges

Consolidated Water Reports 11% Revenue Decline in Q1 2026 Amid Manufacturing Challenges
Trendline Trendline
Rosen Law Firm Investigates Disc Medicine for Potential Securities Claims Following FDA Rejection

Rosen Law Firm Investigates Disc Medicine for Potential Securities Claims Following FDA Rejection

Rosen Law Firm Investigates Disc Medicine for Potential Securities Claims Following FDA Rejection
Trendline Trendline
Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development

Cellular Intelligence Licenses Novo Nordisk's Parkinson's Cell Therapy for AI-Enhanced Development
Trendline Trendline
Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call

Omeros Corporation to Announce First Quarter Financial Results and Host Conference Call
Trendline Trendline
Consolidated Water Reports Decline in Q1 2026 Revenue Amid Weather and Order Timing Challenges

Consolidated Water Reports Decline in Q1 2026 Revenue Amid Weather and Order Timing Challenges

Consolidated Water Reports Decline in Q1 2026 Revenue Amid Weather and Order Timing Challenges
Trendline Trendline
Louisiana-Pacific Reports Q1 2026 Earnings Amid OSB Price Declines and Strategic Expansions

Louisiana-Pacific Reports Q1 2026 Earnings Amid OSB Price Declines and Strategic Expansions

Louisiana-Pacific Reports Q1 2026 Earnings Amid OSB Price Declines and Strategic Expansions